The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1106
ISSUE1106
June 11, 2001
Ziprasidone (Geodon) For Schizophrenia
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ziprasidone (Geodon) For Schizophrenia
June 11, 2001 (Issue: 1106)
Ziprasidone (Geodon - Pfizer), a benzisothiazolyl piperazine, has been approved by the FDA for oral treatment of schizophrenia. An intramuscular formulation will probably be available in the near future.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.